Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 14, 2012

The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical trial on TDI 132 (aka: fingolimod/Gilenya(R)) as a potential treatment for ALS (Lou Gehrig’s disease)

  • Misc. MS Related
    /
Feb 14, 2012 CAMBRIDGE, Mass., Feb. 14, 2012 /PRNewswire-USNewswire/ — The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical…
Misc. MS Related

February 14, 2012

A flowering Tibetan shrub that tricks cells into thinking they are starving could become a weapon against multiple sclerosis and even old age

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
February 13, 2012 The roots of the blue evergreen hydrangea (Dichroa febrifuga) have been used for centuries in traditional Chinese medicine to…
Alternative therapies and devices for Multiple Sclerosis (MS)

February 13, 2012

Masitinib in Patients With Primary Progressive or Relapse-free Secondary Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
A 96 Week, Prospective, Multicentre, Randomized, Double-blind, Placebo-controlled, 2 Parallel-groups, Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib…
MS Drug Therapies

February 11, 2012

Caltech researchers report potential MS breakthrough

  • MS Research Study and Reports
    /
February 9, 2012 Caltech researchers report a possible breakthrough in multiple sclerosis medicine in the latest issue of the Journal of Neuroscience.…
MS Research Study and Reports

February 11, 2012

New book offers advice on speaking to MS patients

  • An MS Patients Story
    /
Author: Ursula Pari, Anchor San Antonio – Dr. Dee Kite has written numerous books from fiction to self-help, but her latest one…
An MS Patients Story

February 11, 2012

Treating Early MS By Targeting Inflammation?

  • Multiple Sclerosis
    /
Laurie L. Barclay, MD Authors and Disclosures Posted: 02/09/2012 Inflammatory Cortical Demyelination in Early Multiple Sclerosis Lucchinetti CF, Popescu BF,…
Multiple Sclerosis

February 10, 2012

An MS Patient’s story on PML

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
Angela created the video found here in October 2010.  This video is very informative and so, I needed to share…
An MS Patients Story

February 10, 2012

an MS Patients’ Story about medication called Nuedexta for Pseudobulbar affect

  • An MS Patients Story
    /
  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
First – for those that do not know, Nuedexta is a new medication for Pseudobulbar Affect. PseudoBulbar Affect is Uncontrollable…
An MS Patients Story

February 9, 2012

ABOUT Half of Patients With MS Do Not Take Disease-Modifying Medication Within Four Years of Diagnosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
A referral to a neurologist may be a mitigating factor for expanded treatment with medication among patients with MS. AMSTERDAM—About…
MS Research Study and Reports

February 9, 2012

Gray Matter Atrophy May Serve as an Effective Outcome Measure for MS Clinical Trials

  • MRI
    /
  • Multiple Sclerosis
    /
Studies show that gray matter atrophy correlates with disability progression and drives whole brain atrophy in MS. AMSTERDAM—Gray matter atrophy…
MRI

Categories

Latest Blog Posts